Sequoia Financial Advisors LLC Has $641,000 Stake in Humana Inc. $HUM

Sequoia Financial Advisors LLC reduced its holdings in shares of Humana Inc. (NYSE:HUM) by 39.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,698 shares of the insurance provider’s stock after selling 2,386 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Humana were worth $641,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in HUM. Montag A & Associates Inc. raised its stake in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the period. CoreCap Advisors LLC increased its holdings in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac acquired a new position in shares of Humana in the fourth quarter valued at $27,000. Reflection Asset Management bought a new position in shares of Humana in the fourth quarter valued at about $29,000. Finally, Larson Financial Group LLC raised its position in shares of Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after purchasing an additional 81 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Trading Up 0.1%

HUM stock opened at $400.51 on Monday. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The company has a market capitalization of $48.09 billion, a PE ratio of 42.84, a price-to-earnings-growth ratio of 2.16 and a beta of 0.71. The company’s 50-day simple moving average is $354.03 and its 200 day simple moving average is $260.20. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping the consensus estimate of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s revenue was up 23.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, sell-side analysts anticipate that Humana Inc. will post 9.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on HUM shares. Wolfe Research raised shares of Humana from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. Needham & Company LLC began coverage on shares of Humana in a report on Wednesday, May 20th. They issued a “buy” rating on the stock. Cantor Fitzgerald raised their price objective on shares of Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 7th. Jefferies Financial Group raised Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. Finally, Guggenheim increased their target price on Humana from $252.00 to $269.00 and gave the stock a “buy” rating in a research note on Thursday, April 30th. Two investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, fifteen have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $325.87.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.